May 22, 2020
Treatment of coagulopathy in COVID-19 patients: protocol for a scoping review
- Hirotaka Mori1,
- Hiroshi Ohkawara1,
- Takayuki Ikezoe1,
- Ryuichi Togawa2,
- Mami Rikimaru2,
- Yoko Shibata2
- 1Department of Hematology, Fukushima Medical University, Fukushima 960-1295, Japan;
- 2Department of Respiratory Medicine, Fukushima Medical University, Fukushima 960-1295, Japan
External link: https://doi.org/10.1007/s12185-021-03084-z
Protocol Citation: Hirotaka Mori, Hiroshi Ohkawara, Takayuki Ikezoe, Ryuichi Togawa, Mami Rikimaru, Yoko Shibata 2020. Treatment of coagulopathy in COVID-19 patients: protocol for a scoping review. protocols.io https://dx.doi.org/10.17504/protocols.io.bgrpjv5n
Manuscript citation:
Mori H, Ohkawara H, Togawa R, Rikimaru M, Shibata Y, Ikezoe T, Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review. International Journal of Hematology doi: 10.1007/s12185-021-03084-z
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: May 22, 2020
Last Modified: May 22, 2020
Protocol Integer ID: 37391
Keywords: COVID-19, coagulopathy, anticoagulant, scoping review,
Abstract
Background
Coronavirus infection disease 2019 (COVID-19) patients have a significant association with coagulopathy and disseminated intravascular coagulation contributing to high mortality. The treatment of COVID-19 and the control of coagulopathy are the primary concern. Although the evidence of anticoagulants in COVID-19 patients with coagulopathy is compiling, there is no scoping review to systematically map the anticoagulants used in this area and to identify the existing gaps between investigated treatment and not. The objective is to conduct a scoping review of available evidence on the anticoagulants in COVID-19 patients with coagulopathy.
Methods
For conducting the scoping review protocol, we will use a scoping review methodology in the Joanna Briggs Institute manual. This methodology has a five-stage approach:
(1) identify the research question; (2) identify relevant studies; (3) select studies; (4) chart the data and (5) collating, summarize and report the results. We also will use the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews to assess the results.
Ethics and dissemination
Because this is a review of the literature, ethics approval is not indicated. We will disseminate the findings from this review in publications in peer-reviewed journals.
Attachments
protocol.pdf
663KB